IDEA: Factors to consider

IDEA: Factors to consider

moasc

2 months
2 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Afsaneh Barzi, MD of Keck School of Medicine discusses the factors to consider in the IDEA collaboration.

Up Next Autoplay
Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
Are These Gene Fusions Targetable? @katherineclift4 @WUSTL
Category: Colorectal Cancer
1 Views
WUSTL 1 week
Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
Anti-EGFR Resistance Mechanism Using Tumor DNA Assay @katherineclift4 @WUSTL
Category: Colorectal Cancer
10 Views
WUSTL 1 week
BEACON Trial: What's Next?
BEACON Trial: What's Next?
Category: Colorectal Cancer
6 Views
Cancer-News 4 weeks
Phase 3 BEACON CRC Trial
Phase 3 BEACON CRC Trial
Category: Colorectal Cancer
66 Views
Cancer-News 4 weeks
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic ...
Category: Colorectal Cancer
26 Views
Cancer-News 1 month
How does this affect treatment?
How does this affect treatment?
Category: Colorectal Cancer
8 Views
Cleveland Clinic 1 month
Is this truly safe?
Is this truly safe?
Category: Colorectal Cancer
2 Views
Cleveland Clinic 1 month
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
Category: Colorectal Cancer
10 Views
Cleveland Clinic 1 month
The impact the IDEA data will have on clinicians
The impact the IDEA data will have on clinicians
Category: Colorectal Cancer
2 Views
moasc 2 months